Search results for "Vaccination"


 
Results 111 - 120 of about 515 for "Vaccination".
Sort by: Relevance | Newest | Oldest

ACP observes National Influenza Vaccination Week, offers resources to physicians

The latest recommended immunization schedule for adults was reviewed and approved in part by ACP and is available online from Annals of Internal Medicine, as are other resources to help increase immunization rates.
https://immattersacp.org/weekly/archives/2017/12/05/6.htm
5 Dec 2017

CDC issues reminder on appropriate use of recombinant zoster vaccine

Early monitoring suggests that clinicians are confusing the administration and storage requirements of the older live attenuated virus vaccine with the recently approved recombinant zoster vaccine, the agency said.
https://immattersacp.org/weekly/archives/2018/06/05/5.htm
5 Jun 2018

ACP releases guidebook on aging, immunity, and importance of vaccination

A free guidebook reinforces the importance of immunization among older adults, especially for vaccine-preventable diseases such as shingles, pneumonia, and influenza.
https://immattersacp.org/weekly/archives/2017/12/19/4.htm
19 Dec 2017

Postexposure prophylaxis drug, vaccine complications, and anticoagulation in COVID-19

A monoclonal antibody combination was effective for postexposure prophylaxis and received emergency use authorization. A study investigated postvaccine myocarditis and pericarditis, and effects of full-dose anticoagulation differed by whether patients were critically ill.
https://immattersacp.org/weekly/archives/2021/08/10/1.htm
10 Aug 2021

Studies find monoclonal antibodies and remdesivir effective, while vaccine-associated myocarditis is rare

A trial of casirivimab plus imdevimab indicated it reduced risk of hospitalization or death, the CDC urged vaccination during pregnancy and updated its v-safe tool, and an analysis showed that postvaccine myocarditis occurred in men and resolved with conservative treatment.
https://immattersacp.org/weekly/archives/2021/10/05/1.htm
5 Oct 2021

New research on PASC, COVID-19 infection and vaccination during pregnancy

Two studies analyzed postacute sequelae of COVID-19 (PASC) in older and ICU patients. Other new research showed that symptomatic infection during delivery raised risks in pregnant women but vaccination during pregnancy was safe. An ACP/Annals of Internal Medicine forum focused on outpatient management of COVID-19, and the FDA issued an emergency use authorization for a new monoclonal antibody treatment.
https://immattersacp.org/weekly/archives/2022/02/15/1.htm
15 Feb 2022

One-fifth of COVID-19 patients taking nirmatrelvir-ritonavir had viral rebound

A small observational study of ambulatory patients with COVID-19 found that 1.8% of untreated patients tested positive again after testing negative, compared to 20.8% of those who took five days of nirmatrelvir-ritonavir.
https://immattersacp.org/weekly/archives/2023/11/14/4.htm
14 Nov 2023

MKSAP Quiz: Routine visit for a patient with chronic kidney disease

A 45-year-old man is evaluated during a routine visit in September. He has advanced chronic kidney disease due to IgA nephropathy. After his vaccination history is evaluated, what is the most appropriate additional vaccine to administer at this visit?
https://immattersacp.org/weekly/archives/2023/07/18/3.htm
18 Jul 2023

Studies look at COVID-19 vaccine boosters; ACP, Annals forum tackles challenging clinical questions

Two Israeli studies showed that vaccine boosters reduced rates of infection and severe disease. Experts gathered for the seventh ACP and Annals of Internal Medicine virtual forum on COVID-19. The FDA authorized a monoclonal antibody for pre-exposure prophylaxis in certain patients.
https://immattersacp.org/weekly/archives/2021/12/14/1.htm
14 Dec 2021

Latest COVID-19 research looks at vaccines' efficacy, thrombocytopenia risk

Thrombosis with thrombocytopenia is a risk with the Johnson & Johnson (Janssen) vaccine, but not those using mRNA technology, one study found, while other research quantified the vaccines' effectiveness over time. A trial found that monoclonal antibodies reduced progression from asymptomatic to symptomatic infection.
https://immattersacp.org/weekly/archives/2022/01/18/1.htm
18 Jan 2022

Result Page: Prev   7   8   9   10   11   12   13   14   15   16   Next